Observational Study of Corneal Opacities in Adults
Trial Summary
What is the purpose of this trial?
A prospective observational study on corneal opacities (scar and stromal dystrophy) in adults (n=150) will be conducted at OHSU. The Optovue anterior segment OCT will be used to perform 3-D corneal scans. These scans will be used to assess opacity depth and measure corneal thickness (pachymetry), corneal topography (anterior and posterior), and epithelial thickness maps. The ultrahigh-speed MIT OCT prototypes will also be used when they become available. A comprehensive eye examination, Placido-ring corneal topography, ultrasound pachymetry, and Scheimpflug camera imaging, will be performed for comparison.
Research Team
David Huang, MD, PhD
Principal Investigator
Oregon Health and Science University
Eligibility Criteria
Inclusion Criteria
Treatment Details
Interventions
- Observational Study (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor
John Hunter
Oregon Health and Science University
Chief Medical Officer since 2024
MD, specific details unavailable
Ann Madden Rice
Oregon Health and Science University
Chief Executive Officer
FACHE certification, extensive leadership experience in academic health centers
National Eye Institute (NEI)
Collaborator
Dr. Michael F. Chiang
National Eye Institute (NEI)
Chief Executive Officer since 2020
MD from Harvard Medical School
Dr. Richard Lee
National Eye Institute (NEI)
Chief Medical Officer since 2021
MD, PhD from Harvard Medical School